BRIEF published on 04/10/2025 at 07:05, 26 days 6 hours ago Relief Therapeutics annonce ses résultats financiers et ses progrès stratégiques pour 2024 Biopharmaceutique Maladies Rares THÉRAPEUTIQUE DE SECOURS Résultats Financiers 2024 Progrès Du Pipeline
BRIEF published on 04/10/2025 at 07:05, 26 days 6 hours ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 26 days 6 hours ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 2 months ago Relief Therapeutics met fin aux discussions de fusion avec Renexxion Valeur Actionnariale Objectifs Stratégiques THÉRAPEUTIQUE DE SECOURS Renexxion Fin De La Fusion
BRIEF published on 03/06/2025 at 07:05, 2 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 2 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
BRIEF published on 02/11/2025 at 07:05, 2 months 23 days ago L'Office européen des brevets accorde un brevet thérapeutique de secours pour le RLF-TD011 Produits Biopharmaceutiques THÉRAPEUTIQUE DE SECOURS RLF-TD011 Brevet Européen Epidermolyse Bulleuse
BRIEF published on 02/11/2025 at 07:05, 2 months 23 days ago European Patent Office Grants Relief Therapeutics Patent for RLF-TD011 Biopharmaceuticals Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
PRESS RELEASE published on 02/11/2025 at 07:00, 2 months 23 days ago Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
BRIEF published on 01/22/2025 at 07:05, 3 months 15 days ago Relief Therapeutics vend les droits de GOLIKE et se concentre sur la R&D THÉRAPEUTIQUE DE SECOURS Vente GOLIKE Partenariat Nutrisens Stratégie Biopharmaceutique Focus R&D
Published on 05/06/2025 at 12:50, 19 minutes ago Skeena Releases 2024 Sustainability Report Entitled "Rebuilding Together"
Published on 05/06/2025 at 12:00, 1 hour 9 minutes ago Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
Published on 05/06/2025 at 08:00, 5 hours 9 minutes ago Pulsar Helium Announces Results of 2025 Annual General and Special Meeting of Shareholders
Published on 05/06/2025 at 01:45, 11 hours 24 minutes ago Forte Group Announces Filing of Fiscal 2024 Audited Financial Statements
Published on 05/06/2025 at 00:20, 12 hours 49 minutes ago McFarlane Lake Announces Listing on the Canadian Securities Exchange (CSE) Effective Thursday, May 8, 2025
Published on 05/06/2025 at 12:25, 44 minutes ago aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
Published on 05/06/2025 at 11:05, 2 hours 4 minutes ago Invitation to the 15th International Investment Forum (IIF) – ONLINE on May 21, 2025
Published on 05/06/2025 at 10:45, 2 hours 24 minutes ago [REMINDER] VAZIVA : Invitation webinaire actionnaires individuels le mercredi 14 mai 2025 à 18h00 - Présentation des Résultats annuels 2024
Published on 05/06/2025 at 10:41, 2 hours 28 minutes ago Successful commissioning of the complete pilot plant for the innovative battery material Silumina Anodes
Published on 05/06/2025 at 10:39, 2 hours 30 minutes ago Solvium: Luxembourg transport logistics fund for institutional investors with unique selling points
Published on 05/06/2025 at 10:31, 2 hours 37 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2025
Published on 05/06/2025 at 10:31, 2 hours 37 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2025
Published on 05/06/2025 at 08:51, 4 hours 18 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 avril 2025
Published on 05/06/2025 at 08:30, 4 hours 39 minutes ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 28/04/2025 tot 02/05/2025
Published on 05/06/2025 at 08:30, 4 hours 39 minutes ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 28/04/2025 au 02/05/2025
